24Jul/13

Genentech's Obinutuzumab (GA101) Delayed Disease Progression Longer … – DailyFinance

Genentech’s Obinutuzumab (GA101) Delayed Disease Progression Longer …
DailyFinance
… monitoring committee determined that the study met its primary endpoint showing that GA101 plus chlorambucil helped people live significantly longer without their disease worsening (progression-free survival; PFS) compared to Rituxan® (rituximab …
Roche antibody tops Rituxan in blood cancer CLLPMLiVE
Genentech Trumpets Phase III Results for CLL CandidateGenetic Engineering News

all 11 news articles »

24Jul/13

Getting the lead out, literally: U.S. Army plans switch to 'green' bullets – Daily Caller

Getting the lead out, literally: U.S. Army plans switch to ‘green’ bullets
Daily Caller
The U.S. Army is taking the expression “get the lead out” quite literally and switching to lead-free, environmentally-friendly bullets. The Army’s Picatinny Arsenal is working on a “green” version of the M80A1 7.62 mm bullet, which troops are supposed …